Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer
ClinicalTrials.gov study NCT04651127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
ClinicalTrials.gov study NCT06248554. IPD Sharing: NO. Countries: 1. Publications: 0.
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
ClinicalTrials.gov study NCT05562830. IPD Sharing: YES. Countries: 10. Publications: 0.
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
ClinicalTrials.gov study NCT05644509. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL
ClinicalTrials.gov study NCT05254899. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT02962804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence
ClinicalTrials.gov study NCT04782804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Estimate Serum Oxytocin PD Range in the Periphery
ClinicalTrials.gov study NCT04431193. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Su
ClinicalTrials.gov study NCT02037074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
ClinicalTrials.gov study NCT04795713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Glofitamab in Combination With PD-1 Antibody and Lenalidomide in Patients With Relapsed/Refractory Large B-cell Lymphoma (LBCL) With TP53 Aberrations: A Prospective, Multice
ClinicalTrials.gov study NCT07240194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion
ClinicalTrials.gov study NCT04034628. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
ClinicalTrials.gov study NCT05856565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
ClinicalTrials.gov study NCT06964568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Visugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
ClinicalTrials.gov study NCT07219459. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT01407003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer
ClinicalTrials.gov study NCT05163483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
ClinicalTrials.gov study NCT03708900. IPD Sharing: YES. Countries: 7. Publications: 0.
PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC
ClinicalTrials.gov study NCT04273100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Keto Acid (KA) on Insulin Resistance in Peritoneal Dialysis (PD) Patients
ClinicalTrials.gov study NCT01496092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.